Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

2005/11/01 by David S. Baldwin, Ian Anderson, David Nutt +8 · 3 citations
Psychology · Medicine · #Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes #Child and Adolescent Psychosocial and Emotional Development #Schizophrenia research and treatment #Anxiety #Psychopharmacology #Psychiatry #Association (psychology) #MEDLINE #Medicine #Psychology #Evidence-based medicine #Clinical Practice #Clinical psychology #Psychotherapist #Alternative medicine #Family medicine

paper · doi:10.1177/0269881105059253

openalex publication_date 2005/11/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Abstract

These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.

Citations

• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
• Efficacy and Safety of Hydroxyzine in the Treatment of Generalized Anxiety Disorder
• The validity of the Hospital Anxiety and Depression Scale
• Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder
• Treatment of panic disorder via the Internet: a randomized trial of CBT vs. applied relaxation
• Pooled Analysis of Antidepressant Levels in Lactating Mothers, Breast Milk, and Nursing Infants
• Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies
• WCA Recommendations for the Long-Term Treatment of Generalized Anxiety Disorder
• Posttraumatic Stress Disorder in the National Comorbidity Survey
• Evidence-based pharmacotherapy of obsessive-compulsive disorder
• Cognitive Behavioral Group Therapy vs Phenelzine Therapy for Social Phobia
• The Hospital Anxiety and Depression Scale
• World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Posttraumatic Stress Disorders

Cited by

• Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003–2010
• Generalised anxiety disorder
• Mood disorder [wikipedia]